OPS is a co-signatory
" We, the undersigned, strongly object to the World Health Organization's (WHO) biased panel tasked with creating new transgender health guidelines. Of the 21 panel members, over three-fourths are transgender activists. The few physicians either specialize in HIV or are “gender doctors.” There is currently a worldwide explosion of teenagers wishing to undergo a sex change; WHO’s stated plan to promote hormones and “legal recognition of self-identified gender” will harm innumerable gender-dysphoric youth, gays, lesbians and other women. WHO must cancel this group's first planned meeting in February and go back to the drawing board.
WHO Should Go Back to the Drawing Board
We call on the World Health Organization (WHO) to participate in, rather than preempt, an open and transparent dialogue about the scientific and societal implications of gender dysphoria treatments, the importance of biological sex, and the best way to protect trans-identified individuals without sacrificing protections for other vulnerable groups including women and children. Such a dialogue requires that a diversity of perspectives from experts and stakeholders be heard, that the public be given sufficient time to weigh in, and that the guideline development group (GDG) take the time and care necessary to understand all the risks, benefits, and unknowns involved, rather than arriving in Geneva with their minds already made up.
On December 18, 2023, WHO announced that it will be developing a guideline on "the health of trans and gender diverse people." WHO also published the names of the 21 guideline panel members who are scheduled to meet from February 19-21, 2024 at WHO's headquarters in Geneva, Switzerland. As part of that announcement, WHO opened a brief window for public comment, scheduled to close on January 8, 2024."